NASDAQ:LXRX

Lexicon Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy LXRX

*Your capital is at risk

$1.85

-0.0400 (-2.12%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

LXRX Prediction Chart

LXRX Predictions History

Latest community submissions for LXRX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
GoldenNugget Pro	May 7, 2019	$6.53 -7.06%	$7.03	X	92.94%	0
NameNotImportant Pro	May 3, 2019	$6.26 -4.57%	$6.56	X	95.43%	0
NameNotImportant Pro	Apr 22, 2019	$5.32 -6.01%	$5.66	X	93.99%	0
PumpTheseNumbers Pro	Mar 25, 2019	$6.83 +20.67%	$5.66	X	79.33%	0
JS Pro	Mar 2, 2017	$15.52 +2.99%	$15.07	X	97.00%	0
Devert @Devert.3418	Mar 2, 2017	$15.79 +4.78%	$15.07	X	95.20%	0
JS Pro	Mar 1, 2017	$15.90 +1.40%	$15.68	X	98.60%	1
JS Pro	Feb 28, 2017	$16.64 +3.74%	$16.04	X	96.30%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LXRX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT LEXICON PHARMACEUTICALS

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The compan...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by